Intranasal and intramuscular H5-Matrix-M nanoparticle vaccines protects against highly pathogenic Influenza A (H5N1) virus in mice [dataset]
Published: 6 July 2026| Version 1 | DOI: 10.17632/x8b2f87c99.1
Contributors:
, , , , , , , , Description
In this work, we characterized the immunogenicity and efficacy of a Matrix-M®–adjuvanted nanoparticle protein vaccine containing recombinant H5 HA of A/American wigeon/South Carolina/22/000345-001/2021 virus (clade 2.3.4.4b, H5-MNP). Influenza A virus (H5N1) animal challenge model involves BL/6 mice and Madin-Darby Canine Kidney epithelial (MDCK) cells. Data types include Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) imputed values from Quant Studio, Focus-forming assay (FFA) values from CTL Biospot, histological images, and weight loss data.
Files
Steps to reproduce
Refer to the Methods sections of the open access manuscript.
Institutions
- Washington University in St. LouisMissouri, St Louis
Categories
Immunology, Vaccine
Funders
- Novavax (United States)Gaithersburg
Additional Metadata for Digital Commons Data@Becker
| Keywords | Influenza Vaccines, Influenza A Virus, H5N1 Subtype, Vaccination |